Company: CI
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001739940-25-000028
Chunk: 192

Company: Cigna Group
Filing Date: 2025-07-31
Form: 10-Q
Item: Part II, Item 12
Chunk 192
---
Note 12 – Fair Value Measurements 

For a description of the policies, methods and assumptions that are used to estimate fair value and determine the fair value hierarchy for each class of financial instruments, see Note 12 in the Company's 2024 Form 10-K.

A.Financial Assets and Financial Liabilities Carried at Fair Value

The following table provides information about the Company's financial assets and liabilities carried at fair value. Further information regarding insurance assets and liabilities carried at fair value is provided in Note 9E to the Consolidated Financial Statements. Separate account assets are also recorded at fair value on the Company's Consolidated Balance Sheets and are reported separately in the Separate Accounts section below as gains and losses related to these assets generally accrue directly to contractholders.(In millions)Quoted Prices in Active Markets for Identical Assets(Level 1)Significant Other Observable Inputs(Level 2)Significant Unobservable Inputs(Level 3)TotalJune 30,2025December 31, 2024June 30,2025December 31, 2024June 30,2025December 31, 2024June 30,2025December 31, 2024Financial assets at fair valueDebt securitiesFederal government and agency$105 $165 $119 $116 $— $— $224 $281 State and local government— — 24 37 — — 24 37 Foreign government— — 401 344 — — 401 344 Corporate— — 7,171 8,049 320 374 7,491 8,423 Mortgage and other asset-backed— — 209 295 40 43 249 338 Total debt securities105 165 7,924 8,841 360 417 8,389 9,423 Equity securities (1)63 1 53 36 2 — 118 37 Short-term investments— — 250 170 — — 250 170 Derivative assets— — 64 168 — — 64 168 Financial liabilities at fair valueDerivative liabilities$— $— $30 $1 $— $— $30 $1 (1)Excludes certain equity securities that have no readily determinable fair value.

21

Level 3 Financial Assets and Financial Liabilities